FDA Weighs Looser Peptide Rules
WASHINGTON, D.C., Los Angeles Times, HealthCareDive, BioSpace, RAPS and Medical Dialogues report that the Food and Drug Administration has scheduled a July advisory review that could reopen compounding access for…
Raw Cheddar Recall in E. Coli Outbreak
ATLANTA, Ga. — U.S. and local health authorities say a multistate E. coli O157:H7 outbreak linked to RAW FARM-brand raw cheddar cheese remains active, with investigators tracing illnesses across multiple…
FDA launches adverse event look-up tool
Silver Spring, Maryland — The U.S. Food and Drug Administration says it has launched a unified platform for collecting and analyzing adverse event reports across regulated product categories, with a…
FDA Clears Lilly’s Foundayo Pill
WASHINGTON — Federal health regulators approved Eli Lilly’s oral obesity medicine Foundayo (orforglipron), creating a new daily pill option in the fast-growing GLP-1 market, according to U.S. Food and Drug…
Novartis Drug Fabhalta Slows Kidney Decline by Nearly Half in Phase III Study
Basel, Switzerland — Novartis announced positive two-year results from its Phase III APPLAUSE-IgAN study, demonstrating that its oral treatment Fabhalta significantly slowed kidney function decline by nearly 50% in adults…
FDA lifts age limit for Neffy
SAN DIEGO, Calif. — The U.S. Food and Drug Administration approved a label update for the 1 mg dose of neffy, an epinephrine nasal spray used in allergic emergencies, removing…
FDA Approves Avlayah for Hunter Syndrome
WASHINGTON — U.S. regulators have granted accelerated approval to Avlayah, a new treatment aimed at neurologic symptoms in children with Hunter syndrome, a rare inherited disorder. Our curated coverage draws…
FDA approves relacorilant for resistant ovarian cancer
Silver Spring, Md. — The U.S. Food and Drug Administration has approved relacorilant (Lifyorli) in combination with nab-paclitaxel for adults with platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer…
FDA Vaccine Chief to Exit in April
WASHINGTON, D.C. — Dr. Vinay Prasad, the FDA’s top vaccines and biologics regulator, will leave the agency at the end of April, a move announced by FDA Commissioner Marty Makary.…
Drug-resistant salmonella tied to moringa capsules
CHICAGO, Feb. 24, 2026 — Federal health officials are warning consumers not to use certain Rosabella brand moringa powder capsules after investigators linked them to an outbreak of extensively drug-resistant…